Novel Compounds For The Treatment Of GI Disorders 682
申请人:Bauer Udo
公开号:US20080262064A1
公开(公告)日:2008-10-23
The present invention relates to novel imidazole compounds having a positive allosteric GABA
B
receptor (CUR) modulator effect, methods for the preparation of said compounds and to their use, optionally in combination with a GABA
B
agonist, for the inhibition of transient lower esophageal sphincter relaxations, for the treatment of gastroesophageal reflux disease, as well as for the treatment of functional gastrointestinal disorders and irritable bowel syndrome (IBS).